Home › NDC Lookup › Ingredients › Loratadine And Pseudoephedrine › 51660-0491-15
⚪image loading
(from DailyMed)

Loratadine and Pseudoephedrine 10 mg; 240 mg Tablet, Extended Release, 15-count — NDC 51660-491-15 (Billing 51660-0491-15)

by Ohm Laboratories Inc. · 15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

This is a package of 15 tablets of Loratadine and Pseudoephedrine 10 mg; 240 mg Tablet, Extended Release from Ohm Laboratories Inc., no longer marketed (first marketed Nov 2004), no longer in the FDA NDC Directory.

NDC 51660-0491-15
🏷️ FDA NDC (as labeled) 51660-491-15 billing pads the product segment with a zero
This package
Contains15-count Pack sizes2 compare ↓
Product page 51660-0491-69 Also comes in: 10 tablets 51660-491-69
OTC Generic Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 51660-491-15
Product NDC 51660-491
11-digit billing NDC 51660049115
RxCUI 1117562
UNII 7AJO3BO7QN, Y9DL7QPE6B
Application # ANDA076557
SPL Set ID bbe83464-a582-469f-8fac-f98e804d96fe
Established class (EPC) alpha-Adrenergic Agonist
Mechanism of action Adrenergic alpha-Agonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status Discontinued
FDA listing status Discontinued by firm
Marketing start 2004-11-17
Route ORAL
Dosage form TABLET, EXTENDED RELEASE
Substance LORATADINE; PSEUDOEPHEDRINE SULFATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 43993002597520
Quick answers
  • GPI-14 (Medi-Span): 43993002597520
  • RxCUI (RxNorm): 1117562
Why two NDCs? The FDA registers this code as 51660-491-15 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 51660-0491-15. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Other antihistamines for systemic use class.

Drug family (ATC) Other antihistamines for systemic use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves allergy symptoms like sneezing, runny nose, itchy, watery eyes, and itching of the nose or throat. It also relieves nasal and sinus congestion from allergie...
  • Swallow the tablet whole with a full glass of water. Never split, crush, chew or dissolve it. Some products are once a day and others are every 12 hours, so check your box and foll...
  • Not if it is an MAOI, or if you stopped one within the last 2 weeks. MAOIs are used for certain depression, psychiatric conditions, and Parkinson's disease. If you are unsure, ask...
  • Taking more than directed may cause drowsiness. Nervousness, dizziness or trouble sleeping can happen too. If any of these occur, stop and talk with your doctor.
📖 Read our full Loratadine / Pseudoephedrine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 10 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
51660-0491-15 You're viewing this 15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK — — 2020-01-15 — Discontinued by firm
51660-0491-69 51660-491-69 Main listing 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK $0.5535 / ea $5.53 2020-01-15 — Active

You're viewing the largest of 2 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 15-count package — 15 tablet, extended release in 1 blister pack.
How does this package differ from NDC 51660-0491-69?
Both are Loratadine and Pseudoephedrine 10 mg; 240 mg Tablet, Extended Release — the drug itself is identical. This page's package is the 15-count one, while NDC 51660-0491-69 is the 10 tablets package.
What NDC number is used to bill for this package of Loratadine and Pseudoephedrine 10 mg; 240 mg Tablet, Extended Release?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
allergy d 10 mg/1; 240 mg 00113-9004-22 L. 1 tablet $0.553 — Availability likely —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 00904-5833-15 Major 10 tablets $0.553 — Availability likely —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 46122-0167-52 Amerisource 10 tablets $0.553 — Availability likely —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 46122-0383-22 AMERISOURCE 15 tablets $0.553 — Availability likely —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 51660-0724-04 Ohm 5 tablets $0.553 — Availability likely —
Leader Allergy Relief D-24 10 mg/1; 240 mg 70000-0162-01 Cardinal 10 tablets $0.553 — Availability likely —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 70677-1018-01 STRATEGIC 10 tablets $0.553 — Availability likely —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 49348-0543-01 STRATEGIC 10 tablets $0.574 — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 62011-0071-01 Strategic 10 tablets $0.574 — FDA listed —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 00363-0725-15 Walgreen 15 tablets — — FDA listed —
Allergy Relief D 10 mg/1; 240 mg 00363-2010-22 Walgreen 1 tablet — — FDA listed —
Claritin-D 24 Hour 10 mg/1; 240 mg 11523-0102-01 Bayer 10 tablets — — FDA listed —
Claritin-D 24 Hour 10 mg/1; 240 mg 11523-4332-01 Bayer 5 tablets — — Discontinued —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 11822-9990-00 Rite 10 tablets — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 21130-0724-15 Safeway 15 tablets — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 30142-0724-15 The 1 tablet — — FDA listed —
allergy congestion relief 10 mg/1; 240 mg 30142-0846-22 Kroger 1 tablet — — FDA listed —
topcare allergy and congestion relief 10 mg/1; 240 mg 36800-0706-22 Topco 1 tablet — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 37808-0427-69 HEB 10 tablets — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 37808-0724-69 HEB 10 tablets — — FDA listed —
Allergy Relief-D 240 mg/1; 10 mg 37808-0787-07 HEB 5 tablets — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 41250-0724-52 Meijer 15 tablets — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 49035-0488-15 WAL-MART 15 tablets — — FDA listed —
Loratadine and Pseudoephedrine 10 mg/1; 240 mgthis 51660-0491-15 Ohm 15 tablets — — Discontinued —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 56062-0724-15 Publix 15 tablets — — FDA listed —
Allergy Relief-D 10 mg/1; 240 mg 59779-0726-15 CVS 5 tablets — — FDA listed —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 63187-0305-10 Proficient 10 tablets — — FDA listed —
kirkland signature allerclear d 24 hr 10 mg/1; 240 mg 63981-0138-22 Costco 1 tablet — — FDA listed —
KIRKLAND SIGNATURE ALLERCLEAR D 24 HR Extended Release 10 mg/1; 240 mg 63981-0724-15 Kirkland-COSTCO 15 tablets — — FDA listed —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 85766-0048-10 Sportpharm 10 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2004
On the market since
Nov 2004
📍
2026
Currently FDA-listed
22 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerOhm Laboratories Inc.
Application holderSUN PHARMACEUTICAL INDUSTRIES LTD
FDA applicationANDA076557 (ANDA)
Labeler code51660
First marketedNov 2004
Product typeHuman Otc Drug
Portfolio30 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 60 words ▾

USES temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: sneezing itchy, watery eyes runny nose itching of the nose or throat reduces swelling of nasal passages temporarily relieves sinus congestion and pressure temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies temporarily restores freer breathing through the nose

⏱️ Dosage and Administration 52 words ▾

DIRECTIONS do not divide, crush, chew or dissolve the tablet adults and children 12 years and over: 1 tablet daily with a full glass of water; not more than 1 tablet in 24 hours children under 12 years of age: ask a doctor consumers with liver or kidney disease: ask a doctor

⚠️ Warnings 196 words ▾

WARNINGS Do not use if you have ever had an allergic reaction to this product or any of its ingredients if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have heart disease thyroid disease high blood pressure diabetes trouble urinating due to an enlarged prostate gland liver or kidney disease.

Your doctor should determine if you need a different dose. When using this product do not take more than directed. Taking more than directed may cause drowsiness.

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away. symptoms do not improve within 7 days or are accompanied by a fever nervousness, dizziness or sleeplessness occurs If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

🧪 Active Ingredient 14 words ▾

ACTIVE INGREDIENTS (IN EACH TABLET) Loratadine, USP 10 mg Pseudoephedrine sulfate, USP 240 mg

🧪 Inactive Ingredients 36 words ▾

INACTIVE INGREDIENTS calcium carbonate, colloidal silicon dioxide, hydroxypropyl cellulose, hypromellose, iron oxide black, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, pregelatinized starch, propylene glycol, shellac glaze, sodium alginate, sodium citrate, talc and titanium dioxide

🎯 Purpose 4 words ▾

PURPOSE Antihistamine Nasal decongestant

📄 Do Not Use 71 words ▾

Do not use if you have ever had an allergic reaction to this product or any of its ingredients if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

📄 Ask a Doctor Before Use If 38 words ▾

Ask a doctor before use if you have heart disease thyroid disease high blood pressure diabetes trouble urinating due to an enlarged prostate gland liver or kidney disease. Your doctor should determine if you need a different dose.

📄 When Using This Product 17 words ▾

When using this product do not take more than directed. Taking more than directed may cause drowsiness.

📄 Stop Use and Ask a Doctor If 37 words ▾

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away. symptoms do not improve within 7 days or are accompanied by a fever nervousness, dizziness or sleeplessness occurs

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📄 Questions or Comments 28 words ▾

QUESTIONS? call 1-800-406-7984 Keep the Carton. It contains important information. See end panel for expiration date. Distributed by: Ohm Laboratories Inc. 1385 Livingston Avenue North Brunswick, NJ 08902

📄 Package Label / Principal Display Panel 218 words ▾

PACKAGE LABEL. PRINCIPAL DISPLAY PANEL NDC 51660-491-69 Original Prescription Strength * Compare to the active ingredients of Claritin-D ® 24 Hour NON-DROWSY ** Allergy Relief & Nasal Decongestant 24 Hour Allergy Relief Loratadine, USP 10 mg/Antihistamine Pseudoephedrine Sulfate, USP 240 mg/Nasal Decongestant Indoor & Outdoor Allergies Relief of: Nasal & Sinus Congestion Due to Colds or Allergies Sneezing Runny Nose Itchy, Watery Eyes Itchy Throat or Nose Due to Allergies Allergy & Congestion 10 Extended-Release Tablets ** When taken as directed.

See Drug Facts Panel. * The product is not manufactured or distributed by Schering-Plough Healthcare Products, Inc. CLARITIN-D ® 24 HOUR is a registered trademark of Schering Corporation. 10s-blister-carton

Principal Display Panel NDC 51660-491-15 Original Prescription Strength * Compare to the active ingredients of Claritin-D ® 24 Hour NON-DROWSY ** Allergy Relief & Nasal Decongestant 24 Hour Allergy Relief Loratadine, USP 15 mg/Antihistamine Pseudoephedrine Sulfate, USP 240 mg/Nasal Decongestant Indoor & Outdoor Allergies Relief of: Nasal & Sinus Congestion Due to Colds or Allergies Sneezing Runny Nose Itchy, Watery Eyes Itchy Throat or Nose Due to Allergies Allergy & Congestion 15 Extended-Release Tablets ** When taken as directed.

See Drug Facts Panel. * The product is not manufactured or distributed by Schering-Plough Healthcare Products, Inc. CLARITIN-D ® 24 HOUR is a registered trademark of Schering Corporation. 15s-blister-carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Loratadine and pseudoephedrine — the ingredient across all brands.

Top reported reactions

Insomnia719
Drug Effect Decreased454
Dizziness376
Somnolence294
Headache283
Nausea279
Fatigue255

Age at onset

Neonate1
Infant4
Child76
Adolescent37
Adult1,062
Elderly621

Reporter sex

7,905 reports
Male · 31%
Female · 69%
Unknown · 0%

Serious outcomes

Hospitalization576
Disabling97
Death88
Life-threatening57
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 312 59
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 10 tablets (51660-0491-69). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Ohm Laboratories Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 51660-0490-41 · Ohm 51660-0492-21 · Ohm →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.